## Glutamate transport is critical for synaptic inactivation of glutamate and prevention of excitotoxicity. The following four glutamate transporters have been identified in human brain: FL4AT1, EAAT2, EAAT3, and W T B Deficient glutamate transport has been identified in the motor cortex and the s
The motor cortex and amyotrophic lateral sclerosis
β Scribed by Andrew Eisen; Markus Weber
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 167 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0148-639X
- DOI
- 10.1002/mus.1042
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
On theoretical grounds, abnormalities of the motor cortex in patients with amyotrophic lateral sclerosis (ALS) could lead to anterograde (βdyingβforwardβ) transneuronal degeneration of the anterior horn cells as suggested by Charcot. Conversely, retrograde (βdyingβbackβ) degeneration of the corticospinal tracts could affect the motor cortex. Evidence derived from clinical, neuropathological, static, and functional imaging, and physiological studies, favors the occurrence of anterograde degeneration. It is hypothesized that transneuronal degeneration in ALS is an active excitotoxic process in which live but dysfunctional corticomotoneurons, originating in the primary motor cortex, drive the anterior horn cell into metabolic deficit. When this is marked, it will result in more rapid and widespread loss of lower motor neurons. In contrast, slow loss of corticomotoneurons, as occurs in primary lateral sclerosis (PLS), precludes excitotoxic drive and is incompatible with anterograde degeneration. Preservation of slowβconducting nonβM1 direct pathways in PLS is not associated with excitotoxicity, and anterior horn cells survive for long periods of time. Β© 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 564β573, 2001
π SIMILAR VOLUMES
## Abstract The aim of this study was to identify a neurophysiological marker of upper motoneuron involvement in patients with sporadic amyotrophic lateral sclerosis (ALS). For this purpose we evaluated the afterβeffects of transcranial directβcurrent stimulation (tDCS) on excitability of the motor
The concept of paraneoplastic disease, a "remote" nonmetastatic effect of cancer, was brought to clinical neurology by Lord Brain in the 1950s. 1 had just begun my own career in neurology and I remember well how From the